# e.l.f. Beauty, Inc.: financial statements, quarterly

ELF · NYSE · CIK 1600033 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/elf.md) · [Financials](/companies/elf/financials.md) · [Filings](/companies/elf/filings.md) · [Insiders](/companies/elf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/elf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [216](/filings/0001600033-26-000020.md) | [271](/filings/0001600033-26-000020.md) | [321](/filings/0001600033-26-000020.md) | [324](/filings/0001600033-26-000020.md) | [301](/filings/0001600033-26-000020.md) | [355](/filings/0001600033-26-000020.md) | [333](/filings/0001600033-26-000020.md) | [354](/filings/0001600033-26-000040.md) | [344](/filings/0001600033-26-000020.md) | [490](/filings/0001600033-26-000020.md) | [449](/filings/0001600033-26-000020.md) | [479](/filings/0001600033-26-000040.md) |
| Cost of revenue | $m | [63.1](/filings/0001600033-24-000050.md) | [79.0](/filings/0001600033-25-000006.md) | [93.9 d](/filings/0001600033-26-000020.md) | [93.2](/filings/0001600033-25-000040.md) | [87.0](/filings/0001600033-25-000058.md) | [102](/filings/0001600033-26-000007.md) | [95.6 d](/filings/0001600033-26-000020.md) | [109](/filings/0001600033-26-000040.md) | [105](/filings/0001600033-25-000058.md) | [142](/filings/0001600033-26-000007.md) | [123 d](/filings/0001600033-26-000020.md) | [80.5](/filings/0001600033-26-000040.md) |
| Gross profit | $m | [152](/filings/0001600033-26-000020.md) | [192](/filings/0001600033-26-000020.md) | [227](/filings/0001600033-26-000020.md) | [231](/filings/0001600033-26-000020.md) | [214](/filings/0001600033-26-000020.md) | [253](/filings/0001600033-26-000020.md) | [237](/filings/0001600033-26-000020.md) | [245](/filings/0001600033-26-000040.md) | [239](/filings/0001600033-26-000020.md) | [347](/filings/0001600033-26-000020.md) | [326](/filings/0001600033-26-000020.md) | [399](/filings/0001600033-26-000040.md) |
| Selling, general and administrative | $m | [112](/filings/0001600033-24-000050.md) | [160](/filings/0001600033-25-000006.md) | [210 d](/filings/0001600033-26-000020.md) | [181](/filings/0001600033-25-000040.md) | [186](/filings/0001600033-25-000058.md) | [218](/filings/0001600033-26-000007.md) | [193 d](/filings/0001600033-26-000020.md) | [196](/filings/0001600033-26-000040.md) | [231](/filings/0001600033-25-000058.md) | [280](/filings/0001600033-26-000007.md) | [319 d](/filings/0001600033-26-000020.md) | [280](/filings/0001600033-26-000040.md) |
| Operating income | $m | [40.2](/filings/0001600033-24-000050.md) | [31.8](/filings/0001600033-25-000006.md) | [17.0 d](/filings/0001600033-26-000020.md) | [50.7](/filings/0001600033-25-000040.md) | [27.9](/filings/0001600033-25-000058.md) | [35.1](/filings/0001600033-26-000007.md) | [44.3 d](/filings/0001600033-26-000020.md) | [48.7](/filings/0001600033-26-000040.md) | [7.7](/filings/0001600033-25-000058.md) | [67.5](/filings/0001600033-26-000007.md) | [(50.3) d](/filings/0001600033-26-000020.md) | [102](/filings/0001600033-26-000040.md) |
| Income tax | $m | [6.5](/filings/0001600033-24-000050.md) | [3.5](/filings/0001600033-25-000006.md) | [(3.3) d](/filings/0001600033-26-000020.md) | [(0.3)](/filings/0001600033-25-000040.md) | [8.9](/filings/0001600033-25-000058.md) | [9.0](/filings/0001600033-26-000007.md) | [15.8 d](/filings/0001600033-26-000020.md) | [17.8](/filings/0001600033-26-000040.md) | [(7.0)](/filings/0001600033-25-000058.md) | [14.5](/filings/0001600033-26-000007.md) | [(11.2) d](/filings/0001600033-26-000020.md) | [27.7](/filings/0001600033-26-000040.md) |
| Net income | $m | [33.3](/filings/0001600033-26-000020.md) | [26.9](/filings/0001600033-26-000020.md) | [14.5](/filings/0001600033-26-000020.md) | [47.6](/filings/0001600033-26-000020.md) | [19.0](/filings/0001600033-26-000020.md) | [17.3](/filings/0001600033-26-000020.md) | [28.3](/filings/0001600033-26-000020.md) | [33.3](/filings/0001600033-26-000040.md) | [3.0](/filings/0001600033-26-000020.md) | [39.4](/filings/0001600033-26-000020.md) | [(49.4)](/filings/0001600033-26-000020.md) | [66.6](/filings/0001600033-26-000040.md) |
| Diluted EPS | $ per share | [0.58](/filings/0001600033-26-000020.md) | [0.46](/filings/0001600033-26-000020.md) | [0.25](/filings/0001600033-26-000020.md) | [0.81](/filings/0001600033-26-000020.md) | [0.33](/filings/0001600033-26-000020.md) | [0.30](/filings/0001600033-26-000020.md) | [0.49](/filings/0001600033-26-000020.md) | [0.58](/filings/0001600033-26-000040.md) | [0.05](/filings/0001600033-26-000020.md) | [0.65](/filings/0001600033-26-000020.md) | [(0.82)](/filings/0001600033-26-000020.md) | [1.12](/filings/0001600033-26-000040.md) |
| Basic EPS | $ per share | [0.61](/filings/0001600033-26-000020.md) | [0.49](/filings/0001600033-26-000020.md) | [0.26](/filings/0001600033-26-000020.md) | [0.85](/filings/0001600033-26-000020.md) | [0.34](/filings/0001600033-26-000020.md) | [0.31](/filings/0001600033-26-000020.md) | [0.50](/filings/0001600033-26-000020.md) | [0.59](/filings/0001600033-26-000040.md) | [0.05](/filings/0001600033-26-000020.md) | [0.66](/filings/0001600033-26-000020.md) | [(0.84)](/filings/0001600033-26-000020.md) | [1.13](/filings/0001600033-26-000040.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [168](/filings/0001600033-24-000050.md) | [72.7](/filings/0001600033-25-000006.md) | [108](/filings/0001600033-25-000016.md) | [109](/filings/0001600033-25-000040.md) | [96.8](/filings/0001600033-25-000058.md) | [73.8](/filings/0001600033-26-000007.md) | [149](/filings/0001600033-26-000020.md) | [170](/filings/0001600033-26-000040.md) | [194](/filings/0001600033-25-000058.md) | [197](/filings/0001600033-26-000007.md) | [290](/filings/0001600033-26-000040.md) | [344](/filings/0001600033-26-000040.md) |
| Current assets | $m | [435](/filings/0001600033-24-000050.md) | [455](/filings/0001600033-25-000006.md) | [477](/filings/0001600033-25-000016.md) | [530](/filings/0001600033-25-000040.md) | [554](/filings/0001600033-25-000058.md) | [559](/filings/0001600033-26-000007.md) | [541](/filings/0001600033-26-000020.md) | [603](/filings/0001600033-26-000040.md) | [707](/filings/0001600033-25-000058.md) | [702](/filings/0001600033-26-000007.md) | [789](/filings/0001600033-26-000040.md) | [860](/filings/0001600033-26-000040.md) |
| Total assets | $m | [747](/filings/0001600033-24-000050.md) | [1,108](/filings/0001600033-25-000006.md) | [1,129](/filings/0001600033-25-000016.md) | [1,205](/filings/0001600033-25-000040.md) | [1,237](/filings/0001600033-25-000058.md) | [1,265](/filings/0001600033-26-000007.md) | [1,248](/filings/0001600033-26-000020.md) | [1,315](/filings/0001600033-26-000040.md) | [2,319](/filings/0001600033-25-000058.md) | [2,324](/filings/0001600033-26-000007.md) | [2,394](/filings/0001600033-26-000040.md) | [2,461](/filings/0001600033-26-000040.md) |
| Current liabilities | $m | [152](/filings/0001600033-24-000050.md) | [303](/filings/0001600033-25-000006.md) | [299](/filings/0001600033-25-000016.md) | [300](/filings/0001600033-25-000040.md) | [311](/filings/0001600033-25-000058.md) | [294](/filings/0001600033-26-000007.md) | [177](/filings/0001600033-26-000020.md) | [185](/filings/0001600033-26-000040.md) | [262](/filings/0001600033-25-000058.md) | [254](/filings/0001600033-26-000007.md) | [336](/filings/0001600033-26-000040.md) | [338](/filings/0001600033-26-000040.md) |
| Total liabilities | $m | [231](/filings/0001600033-24-000050.md) | [494](/filings/0001600033-25-000006.md) | [487](/filings/0001600033-25-000016.md) | [501](/filings/0001600033-25-000040.md) | [509](/filings/0001600033-25-000058.md) | [497](/filings/0001600033-26-000007.md) | [487](/filings/0001600033-26-000020.md) | [510](/filings/0001600033-26-000040.md) | [1,180](/filings/0001600033-25-000058.md) | [1,162](/filings/0001600033-26-000007.md) | [1,264](/filings/0001600033-26-000040.md) | [1,292](/filings/0001600033-26-000040.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [857](/filings/0001600033-25-000058.md) | [849](/filings/0001600033-26-000007.md) | [842](/filings/0001600033-26-000020.md) | [834](/filings/0001600033-26-000040.md) |
| Shareholders' equity | $m | [516](/filings/0001600033-25-000006.md) | [614](/filings/0001600033-25-000006.md) | [643](/filings/0001600033-26-000020.md) | [704](/filings/0001600033-26-000007.md) | [728](/filings/0001600033-26-000007.md) | [767](/filings/0001600033-26-000007.md) | [761](/filings/0001600033-26-000040.md) | [805](/filings/0001600033-26-000040.md) | [1,139](/filings/0001600033-26-000007.md) | [1,162](/filings/0001600033-26-000007.md) | [1,131](/filings/0001600033-26-000040.md) | [1,169](/filings/0001600033-26-000040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [27.9 d](/filings/0001600033-24-000050.md) | [(17.1) d](/filings/0001600033-25-000006.md) | [37.0 d](/filings/0001600033-26-000020.md) | [1.3](/filings/0001600033-25-000040.md) | [11.2 d](/filings/0001600033-25-000058.md) | [(14.7) d](/filings/0001600033-26-000007.md) | [136 d](/filings/0001600033-26-000020.md) | [27.2](/filings/0001600033-26-000040.md) | [23.4 d](/filings/0001600033-25-000058.md) | [59.4 d](/filings/0001600033-26-000007.md) | [102 d](/filings/0001600033-26-000020.md) | [112](/filings/0001600033-26-000040.md) |
| Capital expenditure | $m | [0.8 d](/filings/0001600033-24-000050.md) | [4.5 d](/filings/0001600033-25-000006.md) | [2.7 d](/filings/0001600033-26-000020.md) | [0.8](/filings/0001600033-25-000040.md) | [1.6 d](/filings/0001600033-25-000058.md) | [5.1 d](/filings/0001600033-26-000007.md) | [11.1 d](/filings/0001600033-26-000020.md) | [7.1](/filings/0001600033-26-000040.md) | [6.8 d](/filings/0001600033-25-000058.md) | [6.6 d](/filings/0001600033-26-000007.md) | [1.9 d](/filings/0001600033-26-000020.md) | [1.4](/filings/0001600033-26-000040.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001600033-25-000006.md) | [0.0 d](/filings/0001600033-26-000020.md) | not reported | not reported | [0.0 d](/filings/0001600033-26-000007.md) | [50.0 d](/filings/0001600033-26-000020.md) | [0.0](/filings/0001600033-26-000040.md) | [0.0 d](/filings/0001600033-25-000058.md) | [50.0 d](/filings/0001600033-26-000007.md) | [0.0 d](/filings/0001600033-26-000020.md) | [50.0](/filings/0001600033-26-000040.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.0](/filings/0001600033-23-000048.md) | [55.8](/filings/0001600033-24-000008.md) | [57.2](/filings/0001600033-24-000043.md) | [57.4](/filings/0001600033-24-000050.md) | [58.0](/filings/0001600033-25-000006.md) | [58.6](/filings/0001600033-25-000040.md) | [58.5](/filings/0001600033-25-000058.md) | [58.4](/filings/0001600033-26-000007.md) | [57.7](/filings/0001600033-26-000040.md) | [59.6](/filings/0001600033-25-000058.md) | [60.2](/filings/0001600033-26-000007.md) | [59.7](/filings/0001600033-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 59,007,996 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001600033-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.